Neptune Technologies & Bioressources Inc.

Neptune Technologies & Bioressources Inc. in connection with closing US$34 million transaction with Aker Biomarine Antarctic AS to accelerate business and industry development

Client

Neptune Technologies & Bioressources Inc.

Value

US$34 million

Service

Mergers and Acquisitions

Date Closed

August 2017

Industry

Pharmaceuticals, Biotech & Life Sciences

Lead Office

Montréal

 

On August 8, 2017, Aker Biomarine Antarctic AS (“Aker”) announced its acquisition of Neptune Technologies & Bioressources krill inventory and intellectual property for US$34 million. The acquisition will be used to accelerate business and industry development.

Aker is a Norwegian based biotechnology and krill-harvesting company that develops, markets, and sells krill-based ingredients for nutraceutical, aquaculture, and animal feed applications.

Neptune Technologies & Bioressources is a solution provider of omega-3's and other functional ingredients to branded marketers in the nutraceutical industry, primarily in North America.

Osler, Hoskin & Harcourt LLP represented Neptune Technologies & Bioressources with a team consisting of François Paradis, Mikulas Arendas and Tim Apedaile (Corporate).